Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

Microencapsulated Pomegranate Juice Reduces Metabolic Syndrome (MetS) Criteria in Wistar Rats With MetS Induced With 30% Sucrose

Version 1 : Received: 20 September 2024 / Approved: 23 September 2024 / Online: 23 September 2024 (13:11:46 CEST)

How to cite: Guerrero-Solano, J. A.; Cancino-Díaz, J. C.; Jaramillo-Morales, O. A.; Bautista, M.; Hernández-Uribe, J. P.; Talamantes-Gómez, J. M.; Valadez-Vega, C.; Belefant-Miller, H.; Betanzos-Cabrera, G. Microencapsulated Pomegranate Juice Reduces Metabolic Syndrome (MetS) Criteria in Wistar Rats With MetS Induced With 30% Sucrose. Preprints 2024, 2024091728. https://doi.org/10.20944/preprints202409.1728.v1 Guerrero-Solano, J. A.; Cancino-Díaz, J. C.; Jaramillo-Morales, O. A.; Bautista, M.; Hernández-Uribe, J. P.; Talamantes-Gómez, J. M.; Valadez-Vega, C.; Belefant-Miller, H.; Betanzos-Cabrera, G. Microencapsulated Pomegranate Juice Reduces Metabolic Syndrome (MetS) Criteria in Wistar Rats With MetS Induced With 30% Sucrose. Preprints 2024, 2024091728. https://doi.org/10.20944/preprints202409.1728.v1

Abstract

Pomegranate juice possesses therapeutic properties against metabolic syndrome. Microencapsulation of pomegranate juice (MPJ) may extend its shelf life; however, further research is necessary to ascertain its comparative efficacy with fresh juice. This work evaluated the effect of (MPJ) in an animal model with induced metabolic syndrome (MetS). Male Wistar rats were induced-MetS by administering 30% sucrose orally for 22 weeks. Once MetS was verified in the animals, 7 groups were formed as follows: control (Ctrl); MetS, MetS+Placebo; Ctrl+MPJ; MetS+MPJ1 600, MetS+MPJ2 1800, and MetS+MPJ3 2900 mg/kg. Systolic and diastolic blood pressure, glucose, triglycerides, and total HDL-c levels in the MetS+MPJ groups improved significantly (p < 0.05) vs. the MetS group at the end of the study. Microencapsulation maintained the anti-metabolic syndrome properties of pomegranate juice and could be used to control metabolic syndrome.

Keywords

Metabolic syndrome; Microencapsulated pomegranate juice; Cardiovascular diseases; Punica granatum; Biochemical markers

Subject

Biology and Life Sciences, Food Science and Technology

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.